Correspondence · Write to the Editor
Editorial Inquiries
Corrections, sourcing questions, and reader correspondence are welcome. Medical questions and purchasing inquiries are not appropriate here.
Inscribed · May MMXXVI · Correspondence
Plate I
What to write about
Correspondence is welcome on three topics. First, corrections — any factual error in the cabinet, particularly a mis-cited trial figure, a mis-attributed quotation, or a mis-stated pharmacokinetic value. Second, sourcing requests — a reader who wishes to find the primary publication behind a particular claim, where the inline citation has not made the path clear. Third, editorial suggestions — additional trials, recent publications, or topics that warrant a new cabinet plate.
Readers should write to the editorial address below with a clear subject line, the page in question, and (for corrections) the exact passage at issue. Reasonable correspondence receives a reply; the editorial team is small.
Plate II
What this address is not for
Caveat
Not a medical or purchasing channel
The contact address is not a medical-advice channel. The editor is not qualified to answer clinical questions and will not attempt to do so. Questions about whether tirzepatide is appropriate for an individual, what dose an individual should take, how to manage side effects, or any other clinical matter should be directed to a qualified healthcare provider.
The address is also not a purchasing inquiry channel. Get Tirzepatide does not sell tirzepatide, does not stock tirzepatide, and does not maintain relationships with manufacturers, distributors, compounding pharmacies, or telehealth services. Correspondence asking where tirzepatide may be purchased will not receive a substantive reply.
Plate III
The form
A simple HTML contact form is provided below. Fields: name (optional), email address (required, for reply), subject (required), message (required, up to two thousand characters). Submissions are routed to the editorial inbox; there is no third-party tracking, no analytics on the form fields, and no marketing list. The submission is not logged beyond the editorial inbox.